OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CGRP and Migraine: What Have We Learned From Measuring CGRP in Migraine Patients So Far?
Katharina Kamm
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 28
Katharina Kamm
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Hallmarks of primary headache: part 1 – migraine
Alberto Raggi, Matilde Leonardi, Marco A. Arruda, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 19
Alberto Raggi, Matilde Leonardi, Marco A. Arruda, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 19
Navigating the Neurobiology of Migraine: From Pathways to Potential Therapies
Masaru Tanaka, Bernadett Tuka, László Vécsei
Cells (2024) Vol. 13, Iss. 13, pp. 1098-1098
Open Access | Times Cited: 12
Masaru Tanaka, Bernadett Tuka, László Vécsei
Cells (2024) Vol. 13, Iss. 13, pp. 1098-1098
Open Access | Times Cited: 12
Serum calcitonin gene-related peptide in patients with persistent post-concussion symptoms, including headache: a cohort study
Peter Preben Eggertsen, Johan Palmfeldt, Henrik Winther Schytz, et al.
Journal of Neurology (2024) Vol. 271, Iss. 5, pp. 2458-2472
Open Access | Times Cited: 8
Peter Preben Eggertsen, Johan Palmfeldt, Henrik Winther Schytz, et al.
Journal of Neurology (2024) Vol. 271, Iss. 5, pp. 2458-2472
Open Access | Times Cited: 8
Untangling the mess of CGRP levels as a migraine biomarker: an in-depth literature review and analysis of our experimental experience
Gabriel Gárate, Julio Pascual, Marta Pascual-Mato, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 8
Gabriel Gárate, Julio Pascual, Marta Pascual-Mato, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 8
Serum Alpha and Beta‐CGRP Levels in Chronic Migraine Patients Before and After Monoclonal Antibodies Against CGRP or its Receptor
Gabriel Gárate, Vicente González‐Quintanilla, Andrea González, et al.
Annals of Neurology (2023) Vol. 94, Iss. 2, pp. 285-294
Open Access | Times Cited: 20
Gabriel Gárate, Vicente González‐Quintanilla, Andrea González, et al.
Annals of Neurology (2023) Vol. 94, Iss. 2, pp. 285-294
Open Access | Times Cited: 20
A robust multimodal brain MRI-based diagnostic model for migraine: validation across different migraine phases and longitudinal follow-up data
Jong Young Namgung, Eunchan Noh, Yurim Jang, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Jong Young Namgung, Eunchan Noh, Yurim Jang, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
No change in interictal plasma and salivary CGRP levels in individuals with vestibular migraine corresponding to episodic migraine
Yutong Bai, Min Kyung Chu, Jin-Ju Kang, et al.
Cephalalgia (2025) Vol. 45, Iss. 3
Closed Access
Yutong Bai, Min Kyung Chu, Jin-Ju Kang, et al.
Cephalalgia (2025) Vol. 45, Iss. 3
Closed Access
Efficacy and safety of mAbs anti-CGRP/CGRP R (eptinezumab and erenumab) or atogepant in combination with onabotulinumtoxinA in refractory chronic migraine: a clinical trial protocol
Damiana Scuteri, Gary W. Lawrence, Rosario Iannacchero, et al.
Pain Management (2025), pp. 1-5
Closed Access
Damiana Scuteri, Gary W. Lawrence, Rosario Iannacchero, et al.
Pain Management (2025), pp. 1-5
Closed Access
CGRP: vom Neuropeptid zum therapeutischen Target (Hintergründe und Pathophysiologie)
Katharina Kamm
Nervenheilkunde (2025) Vol. 43, Iss. 04, pp. 222-231
Closed Access
Katharina Kamm
Nervenheilkunde (2025) Vol. 43, Iss. 04, pp. 222-231
Closed Access
Implications of serum calcitonin gene-related peptide and type I interferon in systemic lupus erythematosus-associated headaches
Shu Sugimoto, Yasuhiro Shimojima, Dai Kishida, et al.
Lupus (2025)
Closed Access
Shu Sugimoto, Yasuhiro Shimojima, Dai Kishida, et al.
Lupus (2025)
Closed Access
Migraine and stroke: correlation, coexistence, dependence - a modern perspective
Michał Borończyk, Anna Zduńska, Julia Węgrzynek-Gallina, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Michał Borończyk, Anna Zduńska, Julia Węgrzynek-Gallina, et al.
The Journal of Headache and Pain (2025) Vol. 26, Iss. 1
Open Access
Calcitonin Gene-Related Peptide Levels in Children and Adolescents With Primary Headache Disorder
Mathilde Musoni Falsing, Amalie Akulenok Berring-Uldum, Astrid Førland-Schill, et al.
Journal of Child Neurology (2025)
Closed Access
Mathilde Musoni Falsing, Amalie Akulenok Berring-Uldum, Astrid Førland-Schill, et al.
Journal of Child Neurology (2025)
Closed Access
Enkephalins and Pain Modulation: Mechanisms of Action and Therapeutic Perspectives
Mario García‐Domínguez
Biomolecules (2024) Vol. 14, Iss. 8, pp. 926-926
Open Access | Times Cited: 3
Mario García‐Domínguez
Biomolecules (2024) Vol. 14, Iss. 8, pp. 926-926
Open Access | Times Cited: 3
Rimegepant and atogepant: novel drugs providing innovative opportunities in the management of migraine
William Wells-Gatnik, Lanfranco Pellesi, Paolo Martelletti
Expert Review of Neurotherapeutics (2024), pp. 1-11
Closed Access | Times Cited: 3
William Wells-Gatnik, Lanfranco Pellesi, Paolo Martelletti
Expert Review of Neurotherapeutics (2024), pp. 1-11
Closed Access | Times Cited: 3
Calcitonin gene-related peptide (CGRP) levels in peripheral blood in patients with idiopathic intracranial hypertension and migraine
Ayşın Kısabay Ak, Yağmur İnalkaç Gemici, Melike Batum, et al.
Clinical Neurology and Neurosurgery (2024) Vol. 237, pp. 108136-108136
Closed Access | Times Cited: 2
Ayşın Kısabay Ak, Yağmur İnalkaç Gemici, Melike Batum, et al.
Clinical Neurology and Neurosurgery (2024) Vol. 237, pp. 108136-108136
Closed Access | Times Cited: 2
Characteristics associated with response to subcutaneously administered anti‐CGRP monoclonal antibody medications in a real‐world community cohort of persons living with migraine: A retrospective clinical and genetic study
Bruce A. Chase, Irene Semenov, Susan Rubin, et al.
Headache The Journal of Head and Face Pain (2023) Vol. 64, Iss. 1, pp. 68-92
Open Access | Times Cited: 6
Bruce A. Chase, Irene Semenov, Susan Rubin, et al.
Headache The Journal of Head and Face Pain (2023) Vol. 64, Iss. 1, pp. 68-92
Open Access | Times Cited: 6
Change of CGRP Plasma Concentrations in Migraine after Discontinuation of CGRP-(Receptor) Monoclonal Antibodies
Bianca Raffaelli, Maria Terhart, Mira Pauline Fitzek, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 293-293
Open Access | Times Cited: 5
Bianca Raffaelli, Maria Terhart, Mira Pauline Fitzek, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 293-293
Open Access | Times Cited: 5
Intervening in the Premonitory Phase to Prevent Migraine: Prospects for Pharmacotherapy
Nazia Karsan, Peter J. Goadsby
CNS Drugs (2024) Vol. 38, Iss. 7, pp. 533-546
Closed Access | Times Cited: 1
Nazia Karsan, Peter J. Goadsby
CNS Drugs (2024) Vol. 38, Iss. 7, pp. 533-546
Closed Access | Times Cited: 1
Photophobia and migraine outcome during treatment with galcanezumab
Francesca Schiano di Cola, Giulia Ceccardi, Marco Bolchini, et al.
Frontiers in Neurology (2023) Vol. 13
Open Access | Times Cited: 4
Francesca Schiano di Cola, Giulia Ceccardi, Marco Bolchini, et al.
Frontiers in Neurology (2023) Vol. 13
Open Access | Times Cited: 4
Cortical Hyperperfusion on MRI Arterial Spin-Labeling during the Interictal Period of Patients with Migraine Headache
Masami Shimoda, Kaori Hoshikawa, Shinri Oda, et al.
American Journal of Neuroradiology (2024) Vol. 45, Iss. 6, pp. 686-692
Open Access | Times Cited: 1
Masami Shimoda, Kaori Hoshikawa, Shinri Oda, et al.
American Journal of Neuroradiology (2024) Vol. 45, Iss. 6, pp. 686-692
Open Access | Times Cited: 1
Novel FDA approved zavegepant drug for treating migraine
Usaid Ahmed, Muhammad Meeran Saleem, Mohamed Ashraf Osman, et al.
Annals of Medicine and Surgery (2023) Vol. 86, Iss. 2, pp. 923-925
Open Access | Times Cited: 2
Usaid Ahmed, Muhammad Meeran Saleem, Mohamed Ashraf Osman, et al.
Annals of Medicine and Surgery (2023) Vol. 86, Iss. 2, pp. 923-925
Open Access | Times Cited: 2
CGRP Antagonism and Ketogenic Diet in the Treatment of Migraine
Francesca Finelli, Alessia Catalano, Michele De Lisa, et al.
Medicina (2024) Vol. 60, Iss. 1, pp. 163-163
Open Access
Francesca Finelli, Alessia Catalano, Michele De Lisa, et al.
Medicina (2024) Vol. 60, Iss. 1, pp. 163-163
Open Access
Biomarkers and Endophenotypes of Post-traumatic Headaches
Joshua Kamins, Ramin Karimi, Ann N. Hoffman, et al.
Current Pain and Headache Reports (2024)
Closed Access
Joshua Kamins, Ramin Karimi, Ann N. Hoffman, et al.
Current Pain and Headache Reports (2024)
Closed Access
MRI-ASL-based CBF changesduring the interictal period after anti-CGRP therapy in migraine patients
Masami Shimoda, Kaori Hoshikawa, Shinri Oda, et al.
Research Square (Research Square) (2024)
Closed Access
Masami Shimoda, Kaori Hoshikawa, Shinri Oda, et al.
Research Square (Research Square) (2024)
Closed Access
Calcitonin-Gene-Related Peptide in Migraine and Tension-Type Headache in Children During Interictal Period
Jadranka Sekelj Fureš, Vlasta Đuranović, Jasna Leniček Krleža, et al.
Diagnostics (2024) Vol. 14, Iss. 23, pp. 2645-2645
Open Access
Jadranka Sekelj Fureš, Vlasta Đuranović, Jasna Leniček Krleža, et al.
Diagnostics (2024) Vol. 14, Iss. 23, pp. 2645-2645
Open Access
